Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antitumor Drug Research. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113444108B reveals a novel organocatalytic route for 1,4-sulfur bridge polycyclic compounds, offering high stereoselectivity and mild conditions for API manufacturing.